Corbus Pharmaceuticals(DE:3371)
€2.93+0.07 (+2.45%)
DE:3371
Corbus Pharmaceuticals earnings date
€2.93
At close:+0.07 (+2.45%)
Corbus Pharmaceuticals (3371) Q2 2021 Earnings Report
0 Followers
DE:3371 Q2 2021 EPS Results
- Actual EPS
- -EUR 4.03
- Consensus EPS
- -EUR 3.17
- Beat/Miss
- Missed by -EUR 0.86
- One Year Ago EPS
- -EUR 13.97
DE:3371 Q2 2021 Revenue Results
- Actual Revenue
- EUR 122.27K
- Expected Revenue
- EUR 793.28K
- Beat/Miss
- Missed by -EUR 671.01K
- YoY Revenue Growth
- -52.31%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/12/2021
- Time
- Before Open
- Conference Call
- Thursday, August 12, 2021
DE:3371 Upcoming Earnings
Corbus Pharmaceuticals's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:3371 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -1.27- | -1.12 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -1.14-1.62 | -1.7 | 4.74% (+0.08) | |
| Aug 06, 2026 | 2026 (Q2) | -1.13-1.62 | -1.29 | -25.69% (-0.33) | |
| May 12, 2026 | 2026 (Q1) | -1.09-1.10 | -1.24 | 11.51% (+0.14) | |
| Mar 09, 2026 | 2025 (Q4) | -1.36-1.12 | -0.7 | -60.26% (-0.42) | |
| Nov 12, 2025 | 2025 (Q3) | -1.48-1.70 | -1.03 | -65.22% (-0.67) | |
| Aug 05, 2025 | 2025 (Q2) | -1.34-1.29 | -0.81 | -60.00% (-0.48) | |
| May 06, 2025 | 2025 (Q1) | -1.10-1.24 | -0.74 | -67.47% (-0.50) | |
| Mar 11, 2025 | 2024 (Q4) | -1.13-0.70 | -1.62 | 56.91% (+0.92) | |
| Nov 07, 2024 | 2024 (Q3) | -0.85-1.03 | -2.03 | 49.34% (+1.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

